| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), QURE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 540.3K | $10.48M | - | |
| CFO | 226.6K | $2.05M | - | |
| Other | 133.2K | $3.69M | - | |
| Other | 108.9K | $2.95M | - | |
| Other | 50.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | Post Leonard E | Director | Sell | 389 | $19.73 | $7,674.97 | -3.2% | -8.4% | -67.9% | |
| Feb 27, 2023 | Balachandran Madhavan46 | Director | Sell | 384 | $19.99 | $7,676.16 | -1.9% | -8.4% | -67.9% | |
| Feb 27, 2023 | Caloz Pierre64 | Chief Operating Officer | Sell | 4,365 | $19.61 | $85,608.36 | -3.7% | -8.4% | -67.9% | |
| Feb 27, 2023 | Dolmetsch Ricardo72 | President, R&D | Sell | 6,944 | $19.58 | $135,963.52 | -3.9% | -8.4% | -67.9% | |
| Feb 27, 2023 | Springhorn Jeremy P.46 | Director | Sell | 384 | $20.41 | $7,837.44 | -1.9% | -8.4% | -67.9% | |
| Feb 27, 2023 | Soteropoulos Paula76 | Director | Sell | 384 | $19.97 | $7,668.48 | -2.3% | -8.4% | -67.9% | |
| Feb 27, 2023 | Jacques Rachelle Suzanne45 | Director | Sell | 384 | $20.02 | $7,687.68 | -3.6% | -8.4% | -67.9% | |
| Feb 27, 2023 | Kaye Jack48 | Director | Sell | 384 | $19.99 | $7,676.16 | -1.4% | -8.4% | -67.9% | |
| Feb 27, 2023 | Meek David D.46 | Director | Sell | 389 | $19.71 | $7,667.19 | -2.4% | -8.4% | -67.9% | |
| Jan 18, 2023 | Soteropoulos Paula76 | Director | Sale+OE | 6,000 | $22.59 | $135,540.00 | -26.8% | -12.7% | -75.0% |